Document is current

Any future updates will be listed below

Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II study

Crossref DOI link: https://doi.org/10.1007/s00520-016-3306-z

Published Online: 2016-06-10

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark